Literature DB >> 21372028

The sine qua non of discovering novel biomarkers for early detection of ovarian cancer: carefully selected preclinical samples.

Ian Jacobs1, Usha Menon.   

Abstract

This perspective discusses reports by Cramer and colleagues (beginning on page 365 in this issue of the journal) and Zhu and colleagues (beginning on page 375), which provide the first systematic and reliable comparison of a large number of candidate biomarkers for the early detection of ovarian cancer in a sample set well-suited for this purpose. This research has important implications for the future design of cancer biomarker studies.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21372028     DOI： 10.1158/1940-6207.CAPR-11-0048

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


  9 in total

1.  Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.

Authors:  Hailing Lu; Jon Ladd; Ziding Feng; Mei Wu; Vivian Goodell; Sharon J Pitteri; Christopher I Li; Ross Prentice; Samir M Hanash; Mary L Disis
Journal:  Cancer Prev Res (Phila)       Date:  2012-06-19

2.  A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.

Authors:  Kathryn L Terry; Helena Schock; Renée T Fortner; Anika Hüsing; Raina N Fichorova; Hidemi S Yamamoto; Allison F Vitonis; Theron Johnson; Kim Overvad; Anne Tjønneland; Marie-Christine Boutron-Ruault; Sylvie Mesrine; Gianluca Severi; Laure Dossus; Sabina Rinaldi; Heiner Boeing; Vassiliki Benetou; Pagona Lagiou; Antonia Trichopoulou; Vittorio Krogh; Elisabetta Kuhn; Salvatore Panico; H Bas Bueno-de-Mesquita; N Charlotte Onland-Moret; Petra H Peeters; Inger Torhild Gram; Elisabete Weiderpass; Eric J Duell; Maria-Jose Sanchez; Eva Ardanaz; Nerea Etxezarreta; Carmen Navarro; Annika Idahl; Eva Lundin; Karin Jirström; Jonas Manjer; Nicholas J Wareham; Kay-Tee Khaw; Karl Smith Byrne; Ruth C Travis; Marc J Gunter; Melissa A Merritt; Elio Riboli; Daniel W Cramer; Rudolf Kaaks
Journal:  Clin Cancer Res       Date:  2016-04-08       Impact factor: 12.531

3.  Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer.

Authors:  J W Pedersen; A Gentry-Maharaj; E-O Fourkala; A Dawnay; M Burnell; A Zaikin; A E Pedersen; I Jacobs; U Menon; H H Wandall
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

4.  Aberrant glycosylation associated with enzymes as cancer biomarkers.

Authors:  Danni L Meany; Daniel W Chan
Journal:  Clin Proteomics       Date:  2011-06-03       Impact factor: 3.988

5.  Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.

Authors:  Donavon Hiss
Journal:  J Oncol       Date:  2012-02-06       Impact factor: 4.375

Review 6.  Ovarian cancer screening--current status, future directions.

Authors:  Usha Menon; Michelle Griffin; Aleksandra Gentry-Maharaj
Journal:  Gynecol Oncol       Date:  2013-12-03       Impact factor: 5.482

7.  A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.

Authors:  Annemieke W J Opstal-van Winden; Wendy Rodenburg; Jeroen L A Pennings; Conny T M van Oostrom; Jos H Beijnen; Petra H M Peeters; Carla H van Gils; Annemieke de Vries
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

Review 8.  MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Authors:  Mildred Felder; Arvinder Kapur; Jesus Gonzalez-Bosquet; Sachi Horibata; Joseph Heintz; Ralph Albrecht; Lucas Fass; Justanjyot Kaur; Kevin Hu; Hadi Shojaei; Rebecca J Whelan; Manish S Patankar
Journal:  Mol Cancer       Date:  2014-05-29       Impact factor: 27.401

Review 9.  Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer.

Authors:  Ruchika Bhawal; Ann L Oberg; Sheng Zhang; Manish Kohli
Journal:  Cancers (Basel)       Date:  2020-08-27       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.